lupus

News

FDA knocks back AstraZeneca's self-injected lupus drug

FDA has delivered a setback to AstraZeneca by rebuffing its new formulation of lupus therapy Saphnelo, which was approved in Europe last year.

News

NICE backs Roche lupus drug that supports kidney function

Roche's Gazyvaro, a drug that can restore kidney function in lupus nephritis, has been cleared for use by the NHS in England and Wales.

News

Roche's Gazyva breaks new ground in lupus

Already approved for kidney damage in lupus, Roche's Gazyva could be heading for broader use in the potentially life-threatening autoimmune disorder.

News

AZ's bid for Fasenra approval in COPD falls short

AstraZeneca has abandoned Fasenra development in COPD, but there is better news for the company with a new version of lupus drug Saphnelo.

News

Person holds their hand, radiating pain from the palm.

Data at EULAR back Biogen, UCB's first-in-class lupus drug

Hopes rise for a new treatment option for people living with lupus, after UCB and Biogen reveal phase 3 data with their anti-CD40L antibody DZP.

News

football going into the net past goalkeeper to score

UCB, Biogen lupus drug scores in phase 3 trial

UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of

FDA knocks back AstraZeneca's self-injected lupus drug

NICE backs Roche lupus drug that supports kidney function

Roche's Gazyva breaks new ground in lupus

AZ's bid for Fasenra approval in COPD falls short

Data at EULAR back Biogen, UCB's first-in-class lupus drug

UCB, Biogen lupus drug scores in phase 3 trial

NHS "isn't delivering equitable care for rare diseases"

Using AI-driven synthetic personas to take your insights fur...

lupus

Editor's Picks